We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App





Sysmex Highlights Innovations in Flow Cytometry, Urinalysis and Hematology

By LabMedica International staff writers
Posted on 02 Aug 2018
Print article
Image: The XW-100 CBC analyzer (Photo courtesy of Sysmex).
Image: The XW-100 CBC analyzer (Photo courtesy of Sysmex).
Sysmex (Kobe, Japan) celebrated its 50th anniversary at this year’s annual meeting of the American Association for Clinical Chemistry (AACC) and shared its plans to equip the clinical laboratory of the future with innovative solutions in flow cytometry, urinalysis and hematology. The AACC 2018 held July 29 – August 2 in Chicago, Illinois, USA, was attended by approximately 20,000 clinical laboratory professionals from more than 110 countries.

Sysmex offers clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. The company is innovating across all of its diagnostic practices, including flow cytometry, urinalysis and hematology.

At AACC 2018, Sysmex showcased its first fully automated urine particle analyzer, which reduces the need for manual slide review and delivers first-pass accuracy and unprecedented workflow efficiency. Sysmex’s UN series consists of three analyzer modules and is the first fully configurable urinalysis solution to offer expanded parameters. In addition to being configurable to meet the needs of every laboratory, Sysmex’s solution will allow laboratorians to focus more time on analyzing test results.

Visitors to the Sysmex booth were able to view the company’s new comprehensive flow cytometry system which is highly automated and features a broad portfolio of CyFlow anti-body reagents and the PS-10 sample preparation system with automated cell wash. The new product also includes the XF-1600 flow cytometer with multi-colored capability, high sample throughput and software solutions for the most difficult samples. Sysmex also displayed its FDA-cleared XN-20 complete blood count (CBC) analyzer, a complementary system to its XN-10.

Also on display at Sysmex’s booth at AACC was the automated GloCyte cell counter system, which provides an unprecedented detection level for automated cerebrospinal fluid (CSF) cell counts. Sysmex also showcased its first-of-its-kind XW-100, the world’s first CLIA-waived CBC analyzer that can provide three-part blood test results in as few as three minutes, allowing patients to get answers faster and their physicians to develop treatment plans more quickly.

“As we celebrate five decades of providing laboratories around the world with highly accurate, efficient and dependable diagnostic solutions, we are excited about what we have in store for the laboratory of the future,” said Ralph Taylor, chief executive officer of Sysmex America. “The path to better healthcare is through better testing and Sysmex is lighting the way.”

“Laboratories are facing growing staffing and reimbursement challenges,” said Andy Hay, chief operating officer of Sysmex America. “Sysmex is developing innovative solutions that increase efficiency and allow clinical laboratory professionals to do the work that both ignites their passion for diagnostics and leads to the greatest impact on patient care.”

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.